Pancreatic Enzyme Replacement Therapy to Improve Quality of Life in Patients Undergoing Pancreatoduodenectomy: A Pilot Randomized Controlled Trial (PERQ-UP Pilot)

胰酶替代疗法可改善接受胰十二指肠切除术的患者的生活质量:一项随机对照试验(PERQ-UP 试点)

基本信息

项目摘要

In up to 80% of patients, surgery of the pancreas (most commonly for pancreatic cancer) leads to pancreatic exocrine insufficiency (PEI), a disease where the pancreas no longer makes sufficient digestive enzymes. Tests to diagnose PEI are difficult to per
在高达80%的患者中,胰腺手术(最常见的是胰腺癌)会导致胰腺外分泌不足(PEI),这是一种胰腺不再产生足够消化酶的疾病。诊断PEI的测试很难进行。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karanicolas Paul J其他文献

Karanicolas Paul J的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Karanicolas Paul J', 18)}}的其他基金

The Clinical Evaluation of Adults Undergoing Elective Surgery Utilizing Intraoperative Incisional Wound Irrigation (CLEAN Wound) Trial
利用术中切口伤口冲洗(CLEAN Wound)试验对接受择期手术的成人进行临床评价
  • 批准号:
    466382
  • 财政年份:
    2022
  • 资助金额:
    $ 25.68万
  • 项目类别:
    Operating Grants
The Clinical Evaluation of Adults Undergoing Elective Surgery Utilizing Intraoperative Incisional Wound Irrigation (CLEAN Wound) Trial
利用术中切口伤口冲洗(CLEAN Wound)试验对接受择期手术的成人进行临床评价
  • 批准号:
    474617
  • 财政年份:
    2022
  • 资助金额:
    $ 25.68万
  • 项目类别:
    Operating Grants
Development of the Innovative, Multicentre, Patient-Centred Approach to Clinical Trials in Surgery (IMPACTS) Program
创新、多中心、以患者为中心的外科临床试验方法 (IMPACTS) 计划的开发
  • 批准号:
    398785
  • 财政年份:
    2018
  • 资助金额:
    $ 25.68万
  • 项目类别:
    Operating Grants
The HeLiX Trial: A Randomized Controlled Trial of Tranexamic Acid Versus Placebo to Reduce Perioperative Blood Transfusion in Patients Undergoing Liver Resection
HeLiX 试验:氨甲环酸与安慰剂相比减少肝切除患者围手术期输血的随机对照试验
  • 批准号:
    372220
  • 财政年份:
    2017
  • 资助金额:
    $ 25.68万
  • 项目类别:
    Operating Grants
The HeLiX Trial: A Randomized Controlled Trial of Tranexamic Acid Versus Placebo to Reduce Perioperative Blood Transfusion in Patients Undergoing Liver Resection
HeLiX 试验:氨甲环酸与安慰剂相比减少肝切除患者围手术期输血的随机对照试验
  • 批准号:
    351765
  • 财政年份:
    2016
  • 资助金额:
    $ 25.68万
  • 项目类别:
    Operating Grants
The HeLiX Trial: A Randomized Controlled Trial of Tranexamic Acid Versus Placebo to Reduce Perioperative Blood Transfusion in Patients Undergoing Liver Resection
HeLiX 试验:氨甲环酸与安慰剂相比减少肝切除患者围手术期输血的随机对照试验
  • 批准号:
    366542
  • 财政年份:
    2016
  • 资助金额:
    $ 25.68万
  • 项目类别:
    Operating Grants
HPB CONCEPT: An Integrated Program to Improve Outcomes Following Liver and Pancreas Surgery
HPB 概念:改善肝脏和胰腺手术后结果的综合计划
  • 批准号:
    320002
  • 财政年份:
    2014
  • 资助金额:
    $ 25.68万
  • 项目类别:
    Salary Programs
Tranexamic Acid Versus Placebo to Reduce Perioperative Blood Transfusion in Patients Undergoing Major Liver Resection: A Pilot Randomized Controlled Trial
氨甲环酸与安慰剂相比,可减少接受主要肝切除术的患者围手术期输血:一项随机对照试验
  • 批准号:
    297779
  • 财政年份:
    2013
  • 资助金额:
    $ 25.68万
  • 项目类别:
    Operating Grants
Establishment of the Hepatopancreaticobiliary Community of Surgical Oncologists: Clinical, Evaluative, and Prospective Trials Team (HPB CONCEPT Team)
建立肝胰胆外科肿瘤学家社区:临床、评估和前瞻性试验团队(HPB CONCEPT 团队)
  • 批准号:
    271172
  • 财政年份:
    2012
  • 资助金额:
    $ 25.68万
  • 项目类别:
    Miscellaneous Programs

相似海外基金

A novel highly stable pancreatic enzyme replacement therapy to improve outcomes for patients with pancreatic insufficiency.
一种新型高度稳定的胰酶替代疗法,可改善胰腺功能不全患者的预后。
  • 批准号:
    10543210
  • 财政年份:
    2022
  • 资助金额:
    $ 25.68万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了